From April 1, 2021 to June 30, 2021, the company has repurchased 1,624,546 shares, representing 1.62% for $5.7 million. With this, the company has completed the repurchase of 3,250,193 shares, representing 3.23% for $12 million under the buyback announced on November 4, 2020.
BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+54.61% | 811B | |
+43.68% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.85% | 246B | |
+2.58% | 225B | |
+13.01% | 218B | |
+8.61% | 168B |